待处理
入排:排除
图源:待检查
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study.
John E Harris, Kim Papp, Khaled Ezzedine, Michael Sebastian, Amit G Pandya, Julien Seneschal, Mark Amster, Maryam Shayesteh Alam, Seth B Forman, Jacek Zdybski, Anthony Nuara, Deanna Kornacki, Shaoceng Wei, Thierry Passeron, David Rosmarin
Br J Dermatol 194(5) 971-973
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板